Horm Metab Res 1995; 27(4): 185-188
DOI: 10.1055/s-2007-979936
Originals Clinical

© Georg Thieme Verlag Stuttgart · New York

Do “So-Called” Normal Growth Hormone Concentrations (2-5 µg/l) Indicate Cure in Acromegaly?

Naomi S. Levitt1 , B. D. Ratanjee1 , M. J. Abrahamson2
  • 1Department of Medicine, University of Cape Town, Cape Town, South Africa
  • 2Department of Medicine Beth Israel Hospital and Harvard Medical School Boston, U.S.A.
Further Information

Publication History

1994

1995

Publication Date:
23 April 2007 (online)

Abstract

The study was undertaken to determine whether acromegalic patients with mean growth hormone (GH) concentrations of 2-5 µg/l have biochemically active disease following pituitary surgery or radiotherapy. 22 patients with acromegaly, 22 post surgery, 19 post radiotherapy had GH concentrations estimated during: (i) an oral glucose tolerance test (OGTT), (ii) a standard TRH test and (iii) 20 minute sampling for 8 hours. IGF-1 concentrations were measured. 6 normal subjects were also studied. Patients were divided into 3 groups on the basis of their mean GH concentration during the 8 hour sampling, > 5 µg/l, 2-5 µg/l, < 2 µg/l. Patients with mean GH concentrations of 2-5 µg/l (n = 6) had biochemically active disease: all had inadequate suppression of GH after OGTT, 5 had elevated IGF-1 concentrations, 4 had a paradoxical response to TRH. Patients with mean GH concentrations > 5 µg/l (n = 6) all had inadequate suppression after OGTT, 5 of 6 had increased IGF-1 concentrations, and 5 had abnormal responses to TRH. Of patients with mean GH concentrations < 2 µg/l (n = 10), 2 had elevated IGF-1 levels, 5 had abnormal responses to TRH and 4 inadequate GH suppression after OGTT. GH pulse number was similar in the three groups and GH pulse amplitude was significantly higher in those with GH > 5 µg/l compared to the other groups. In conclusion patients with GH concentrations of 2-5 µg/l have biochemically active disease and should be considered for further therapy after hypophysectomy.